Patent information
IP India · live recordApplication number
202317083196
Filing date
06 December 2023
Status
Application Awaiting Examination
Publication number
39/2024
Publication type
INA
Invention field
Chemical
Abstract
Provided are octavalent influenza vaccine compositions comprising eight mRNA, each mRNA comprising an open reading frame encoding a different influenza antigen. Also provided are lipid nanoparticles (LNPs) for delivering said mRNA.
Applicants
1France
SANOFI
46 avenue de la Grande Armée
75017 Paris
Inventors
2U.S.A.
ALEFANTIS, Timothyc/o Sanofi, Patent Department
50 Binney Street
Cambridge, Massachusetts 02142
U.S.A.
CHIVUKULA, Sudhac/o Sanofi, Patent Department
50 Binney Street
Cambridge, Massachusetts 02142
Documents
Sign in to openApplication documents
1
202317083196-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [06-12-2023(online)].pdf
06 Dec 2023
2
202317083196-STATEMENT OF UNDERTAKING (FORM 3) [06-12-2023(online)].pdf
06 Dec 2023
3
202317083196-Sequence Listing in txt [06-12-2023(online)].txt
06 Dec 2023
4
202317083196-Sequence Listing in PDF [06-12-2023(online)].pdf
06 Dec 2023
5
202317083196-FORM 1 [06-12-2023(online)].pdf
06 Dec 2023
6
202317083196-DRAWINGS [06-12-2023(online)].pdf
06 Dec 2023
7
202317083196-DECLARATION OF INVENTORSHIP (FORM 5) [06-12-2023(online)].pdf
06 Dec 2023
8
202317083196-COMPLETE SPECIFICATION [06-12-2023(online)].pdf
06 Dec 2023
9
202317083196-FORM-26 [09-02-2024(online)].pdf
09 Feb 2024
10
202317083196-FORM 3 [28-05-2024(online)].pdf
28 May 2024
11
202317083196-Proof of Right [20-01-2025(online)].pdf
20 Jan 2025
12
202317083196-PA [27-05-2025(online)].pdf
27 May 2025
13
202317083196-ASSIGNMENT DOCUMENTS [27-05-2025(online)].pdf
27 May 2025
14
202317083196-8(i)-Substitution-Change Of Applicant - Form 6 [27-05-2025(online)].pdf
27 May 2025
15
202317083196-FORM 18 [10-06-2025(online)].pdf
10 Jun 2025